MAP4K4 and spindle cell hemangioma: For example, GDC + SCH-resistant cells were inhibited to different degrees by all of the PKA, MAP4K4 and PKG2 inhibitors and these effects were surprisingly diminished by co-treatment with GDC and SCH.